Introduction Alzheimer’s disease remains one of the most challenging neurodegenerative disorders in the UK and Europe. It gradually impairs memory, cognition, and daily functioning, affecting millions of families emotionally and financially. While traditional pharmaceutical approaches provide limited symptom relief, emerging research suggests that alternative therapies, particularly psychedelic compounds like psilocybin from magic mushrooms and Ibogaine […]